By: IPP Bureau
Last updated : February 05, 2022 1:31 pm
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
Financial Results (Q3 FY2022) - QoQ comparison
The company has reported a total income of Rs. 62.49 crore during the period ended December 31, 2021 as compared to Rs. 33.85 crore during the period ended September 30, 2021.
The company has incurred a loss of Rs. -15.84 crore for the period ended December 31, 2021 as against a loss of Rs. -55.14 crore for the period ended September 30, 2021.
Financial Results (Q3 FY2022) - YoY comparison
The company has reported a total income of Rs. 62.49 crore during the period ended December 31, 2021 as compared to Rs.23.41 crore during the period ended December 31, 2020.
The company has incurred a loss of Rs.-15.84 crore for the period ended December 31, 2021 as against a loss of Rs.-67.62 crores for the period ended December 31, 2020.
Financial Results (nine-month ended FY2022) - YoY comparison
The company has reported a total income of Rs.118.63 crore during the nine-month period ended December 31, 2021 as compared to Rs.229.98 crore during the nine-month period ended December 31, 2020.
The company has incurred a loss of Rs.-132.35 crore for the nine-month period ended December 31, 2021 as against a loss of Rs.-94.42 crore for the nine-month period ended December 31, 2020.